Multi-site Evaluation of Partnered Pharmacist Medication Charting and in-hospital Length of Stay.
To undertake a multi-centre evaluation of translation of a partnered pharmacist medication charting (PPMC) model in patients admitted to General Medical Units in public hospitals in the state of Victoria, Australia. Unblinded, prospective cohort study comparing patients before and after the intervention SETTING: Seven public hospitals in Victoria, Australia from 20 Jun 2016 to 30 June 2017. Patients admitted to General Medical Units. Medication charting by pharmacists using a partnered pharmacist model compared to traditional medication charting. The primary outcome variable was the length of inpatient hospital stay. Secondary outcome measures were medication errors detected within 24 hours of the patients' admission, identified by an independent pharmacist assessor. A total of 8,648 patients were included in the study. Patients who had PPMC had reduced median length of inpatient hospital stay from 4.7 (IQR 2.8-8.2) days to 4.2 (IQR 2.3-7.5) days (p<0.001). PPMC was associated with a reduction in the proportion of patients with at least one medication error from 66% to 3.6% with a NNT to prevent one error of 1.6 (95% CI: 1.57-1.64). Expansion of the partnered pharmacist charting model across multiple organisations was effective and feasible and is recommended for adoption by health services.